In late 2013,a public awareness campaign was initiated after electromechanical morcellation (EMM) of a uterus with presumed benign leiomyoma, which in fact was leiomyosarcoma (LMS). Over the past year, the focus of the medical community has been on the incidence of occult LMS, specifically related to EMM. The risk of intracorporeal tissue dissemination by EMM resulted in some manufacturers halting sales of theEMM device, various hospitals banning the procedure, and ultimately a black box warning from the US Food and DrugAdministration (FDA) for electromechanical morcellators.
The Dilemma of Myomectomy, Morcellation, and the Demand for Reliable Metrics on Surgical Quality
About the Author: Dr. Ceana Nezhat
Ceana Nezhat, MD is a world‐renowned gynecological surgeon and medical director of Nezhat Medical Center in Atlanta, which specializes in minimally invasive surgical treatment of severe and multi‐organ endometriosis, infertility, and urologic and pelvic reconstruction. He has developed techniques and refined instrumentation for minimally invasive surgery for the benefit of patients globally.